Omalızumab ELISA (mAb-based)

Enzyme immunoassay for the specific quantitative determination of free Omalizumab (Xolair®) in serum and plasma.

The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Omalizumab.  Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.

Reference: IG-AB111

Barcode: 8682754930271

Legal Status: CE-Mark

Intended Use: This kit has been developed for the measurement of drug levels in research, diagnostic and biosimilar uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

Related Documents

Quality Control Certificates

Xolair® is a trademark of Genentech Inc.

Required Volume (µL) 10
Incubation Time (min) 100
Sample Serum or Plasma
Package Size 96 Tests
Standard Range (ng/mL, 10x) 0-1000
Detection Limit (ng/mL) 2
Spike Recovery (%) >95
Shelf Life (years) 2